Mosby's Pharmacology Memory NoteCards - Elsevier eBook on VitalSource, 7th Edition

by JoAnn Zerwekh, EdD, MSN, RN and Ashley Zerwekh Garneau, PhD, RN

Elsevier eBook on VitalSource

ISBN: 9780443112614

Publication Date: 03-04-2024

Page Count: 248

Imprint: Mosby

List Price: $26.99

Most review copies are eBooks – how fast!

A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Elsevier Sales Rep.

An Access Code

Important note

You are viewing the faculty version.

Students requesting access will be reported.

Student access

Technical Support

Contact your Elsevier Sales Rep to learn more about adopting this product

More than 100 colorful flashcards bring pharmacology review to life! Mosby’s Pharmacology Memory NoteCards: Visual, 7th Edition uses cartoons, humor, concise summaries, and mnemonics to make studying easier and more fun. These unique cards may be used as either a spiral-bound notebook or detached for use as individual flashcards, so they are perfect for studying while on the go. Ideal for visual learners, these durable notecards will help students prepare for class, clinicals, or the NCLEX^® examination. There’s no other study tool like it!

Related Products
Key Features
- NEW! Four brand-new cards are added on these topics: neomycin-polymyxin-HC (c-sporin solution), CNS stimulants (Adderall XR), fat-soluble vitamins (Vitamins ADEK), and water-soluble vitamins (Vitamins B and C)
- NEW! New drug categories are added for the eye and ear, antifungals, and vitamins and minerals including water-soluble vitamins, fat-soluble vitamins, ferrous sulfate, and calcium supplements
- UNIQUE! Color-highlighted monographs include drug uses, contraindications and precautions, side effects, important nursing implications, serious/life-threatening implications, and patient teaching, making it easier remember nursing priorities on common medications
- UNIQUE! Mnemonics and other time-tested memory aids help students grasp and remember even the most complex concepts
- UNIQUE! More than 100 full-color cartoons offer humorous and memorable presentations of key drugs, and are ideal for visual learners
- What You Need to Know sections on each card cover key information in a quick and easy-to-review format
- Thick pages and a spiral-bound format create a portable tool that is durable enough for the clinical environment
- Colored thumb tabs at the bottom of the page allow users to find topics quickly
New to This Edition
- NEW! Four brand-new cards are added on these topics: neomycin-polymyxin-HC (c-sporin solution), CNS stimulants (Adderall XR), fat-soluble vitamins (Vitamins ADEK), and water-soluble vitamins (Vitamins B and C)
- NEW! New drug categories are added for the eye and ear, antifungals, and vitamins and minerals including water-soluble vitamins, fat-soluble vitamins, ferrous sulfate, and calcium supplements
Contents

ADMINISTRATION
Medication Administration
Medication Calculation
Medication Safety
Ear and Eye Drop Administration
Peak and Trough
Guide to Drug Overdose
Administration of Medications by Inhalation
Transdermal Medication Administration

ANALGESICS AND NSAIDs
Morphine Sulfate
Analgesics: Moderate-to-Strong Opioid Agents
Opioid Antagonists: Naloxone (Narcan)
Acetylsalicylic Acid—Aspirin
First-Generation NSAIDs—Nonaspirin
Second-Generation NSAIDs (COX-2 Inhibitor or Coxibs)
Acetaminophen (Tylenol)
Fentanyl
Salicylate (Aspirin) Poisoning

ANTIBIOTICS / ANTIVIRALS / ANTIFUNGALS
Cephalosporins
Tetracyclines
Metronidazole (Flagyl)
Isoniazid
Aminoglycosides
Aminoglycoside Toxicity
Antiretrovirals
Pre-Exposure Prophylaxis
Quinolones and Tetracyclines–Drug Impact on Pregnancies
Fluoroquinolones
Penicillin
Macrolides
The Azoles
Mupirocin

ANTICOAGULANTS AND HEMATINICS
Heparin
Enoxaparin (Lovenox)
Warfarin Sodium (Coumadin)
Epoetin Alfa (Procrit)
Thrombolytics
Clopidogrel (Plavix)
Argatroban
Anticoagulants for Atrial Fibrillation

CARDIAC
Calcium Channel Blockers and Beta-Blockers
Antihypertensive Drugs
Angiotensin-Converting Enzyme (ACE) Inhibitors
Atropine Side Effects
Potassium Chloride (Intravenous and Oral)
Emergency Drugs
Calcium Channel Blockers
Angiotensin II Receptor Blockers (ARBs)
Nitroglycerin
Antidysrhythmics
Digoxin
Lidocaine Toxicity
Drugs for Bradycardia and Decreased BP
Alpha-Adrenergic Antagonists (Alpha-Blockers) Side Effects
Beta-Adrenergic Antagonists (Beta-Blockers) Side Effects
HMG-CoA Reductase Inhibitors (Statins)

CENTRAL NERVOUS SYSTEM
Antiepileptic Drugs
Gabapentin (Neurontin)
Promethazine (Phenergan)
Midazolam (Versed)
Benzodiazepine-Like Drugs
Ondansetron (Zofran)
CORTICOSTEROIDS
Corticosteroids
Clobetasol
DIURETICS
Diuretics
Furosemide (Lasix)
Hydrochlorothiazide
Spironolactone (Aldactone)

ENDOCRINE
Types of Insulin
Oral Antidiabetic Drugs and Noninsulin Injectable Agents
Sulfonylureas
Metformin (Glucophage)
Levothyroxine (Synthroid)

EYE AND EAR
Drugs for Age-Related Macular Degeneration
Drugs for Glaucoma
Ciprofloxacin/Dexamethasone (Ciprodex)

GASTROINTESTINAL
H2-Receptor Antagonists
Psyllium (Metamucil)
Proton Pump Inhibitors
Magnesium Hydroxide (Milk of Magnesia)
Aluminum Hydroxide
Antidiarrheals
Lactulose

MISCELLANEOUS
Toxic Levels of Lithium, Digoxin, and Theophylline
Drug Interactions and Grapefruit
Cancer Chemotherapy: Adverse Reactions and Precautions
Sunscreens

MUSCULOSKELETAL
Antigout Agents
Disease-Modifying Antirheumatic Drugs (DMARDs)
Bisphosphonate Therapy

PSYCHIATRIC
Selective Serotonin Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Tricyclic Antidepressants (TCAs)
Haloperidol
Alzheimer Disease Drugs (AD)
CNS Stimulants

PULMONARY
Antihistamines
Bronchodilators
Advair and Spiriva
Antitussives, Expectorants, and Mucolytics

REPRODUCTIVE / OBSTETRICS
Drugs for Cervical Ripening: Prostaglandins
Oxytocin (Pitocin),
Rho (D) Immune Globulin (RhoGAM)
Anticholinergic Drugs for Overactive Bladder
Oral Contraceptives: Serious Adverse Effects
Erectile Dysfunction Drugs
Drugs for Benign Prostatic Hyperplasia

VITAMINS AND MINERALS
Iron Supplements (Oral Ferrous Iron Salts)
Oral Calcium Supplements
Pyridoxine (Vitamin B6): Isoniazid and Levodopa
Cyanocobalamin (Vitamin B12)
Folic Acid
Fat-Soluble Vitamins (Vitamins A, D, E, K)
Water-Soluble Vitamins (Vitamins B, C)
Authors

JoAnn Zerwekh, EdD, MSN, RN, President/CEO, Nursing Education Consultants, Inc., Chandler, Arizona, USA and Ashley Zerwekh Garneau, PhD, RN, Nursing Faculty, Department of Nursing, GateWay Community College, Phoenix, Arizona, USA
Accessibility
- Ways of Reading
  - The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
  - This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
  - All content can be read as read aloud speech or dynamic braille
  - Has alternative text descriptions for images
- Conformance
  - The publication contains a conformance statement that it meets the EPUB Accessibility 1.1, WCAG 2.1, Level AA standard. Please see https://bornaccessible.benetech.org/certified-publishers/ for further details of our compatibility testing.
  - The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
  - For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
  - For queries regarding accessibility information, contact [email protected]
  - The publication was certified on 06-02-2026
- Navigation
  - Table of contents to all chapters of the text via links
  - Index with links to referenced entries
  - Elements such as headings, tables, etc. for structured navigation
  - Page list to go to pages from the print source version
- Rich Content
  - Information-rich images are described by extended descriptions
- Hazards
  - The publication contains no hazards
- Product Content
  - The primary content is text.
  - Content includes a significant number of actionable (clickable) web links to external content, downloadable resources, supplementary material, etc.
  - Content includes a significant number of actionable (clickable) cross-references, hyperlinked notes and annotations, or with other actionable links between largely textual elements (e.g., quiz/test questions, 'choose your own ending', etc.).
  - Content includes figures, diagrams, charts and/or graphs, including other 'mechanical' (i.e. non-photographic) illustrations.
  - Content includes images displayed in a specific order for the purpose of graphic storytelling or giving information (e.g. graphic novels, comics and manga). May include text integrated into the image (as speech and thought bubbles, textual 'sound' effects, captions etc.).
  - Content includes text within images, including text-as-text embedded in diagrams, charts, or within images containing speech balloons, thought bubbles, captions, etc.
  - Content includes visual content that is purely decorative and is not necessary to understanding of the content.
  - At least some text - including text within other images - is 'text as an image' (i.e., a picture of text).
- Legal Considerations
  - No information is available
- Additional Accessibility Information
  - Content is enhanced with ARIA roles to optimize organization and facilitate navigation
  - Page breaks included from the original print source
  - For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
  - The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
  - Ultra-high contrast between text and background
  - E-publication includes basic navigation (usually less detailed than TOC-based navigation)
  - Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
  - All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
  - Content provides explanations for unusual words, abbreviations, acronyms, idioms, jargon in an accessible form, such as glossaries, scripted pop-ups.
  - Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
  - The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.